The HLA-E locus is associated with age at onset and susceptibility to type 1 diabetes mellitus

Human Immunology

Volumn 61, Issue 3, 2000, Pages 290-295

  Hodgkinson, Andrea Dawn ^a   Millward, Beverley Ann ^a   Demaine, Andrew Glenn ^a  

^a PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

Author keywords

Autoimmunity; HLA E; Immunogenetics; Major histocompatibility complex; NK cells; Type 1 diabetes mellitus

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA E ANTIGEN;

ALLELE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENETIC POLYMORPHISM; HUMAN; IMMUNOGENETICS; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; ONSET AGE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; GREAT BRITAIN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; MALE; POLYMORPHISM, GENETIC;

EID: 0034000488     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(99)00116-0     Document Type: Article

References (20)

1. Platz P., Jakobsen B.K., Morling N., Ryder L.P., Svejgaard A., Thomsen A., Christy M., Kromann H., Benn J., Nerup J., Green A., Hauge M. HLA-D and -DR antigens in genetic analysis of insulin-dependent diabetes mellitus. Diabetologia. 21:1981;108.
2. Wolf E., Spencer K.M., Cudworth A.G. The genetic susceptibility to type 1 diabetes analysis of the HLA-DR association. Diabetologia. 24:1983;224.
3. Todd J.A. Genetic analysis of type 1 diabetes using whole genome approaches. Proc Natl Acad Sci. 92:1995;8560.
4. Pociot F., Briant L., Jongeneel C.V., Molvig J., Worsaae H., Abbal M., Thomsen M., Nerup J., Cambon-Thomsen A. Association of tumour necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells a possible link to insulin dependent diabetes mellitus. Eur J Immunol. 23:1993;224.
5. Hanifi Moghaddam P., de Knijf P., Roep B.O., van der Auwera B., Naipal A., Gorus F., Schuit F., Giphart M.J. Genetic structure of IDDM1 two separate regions in the major histocompatibility complex contribute to susceptibility or protection. Diabetes. 47:1998;263.
6. Fennessy M., Metcalfe K., Hitman G.A., Niven M., Biro P.A., Tuomilehto J., Tuomilehto-Wolf E. A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Diabetologia. 37:1994;937.
7. Nejentsev S., Reijonen H., Adojaan B., Kovalchuk L., Sochnevs A., Schwartz E.I., Akerblom H.K., Ilonen J. The effect of HLA-B allele on the IDDM risk defined by DRB1*04 subtypes and DQB1*0302. Diabetes. 46:1997;1888.
8. Faustman K., Li X., Lin H.Y., Fu Y., Eisenbarth G., Avruch J., Guo J. Linkage of faulty major histocompatibility complex class 1 to autoimmune diabetes. Science. 254:1991;1756.
9. Nakanishi K., Kobayashi T., Murase T., Nakatsuji T., Inoko H., Tsuji K., Kosaka K. Association of HLA-A24 with complete β-cell destruction in IDDM. Diabetes. 42:1993;1086.
10. Fujisawa T., Ikegami H., Kawaguchi Y., Yamato E., Takekawa K., Nakagawa Y., Hamada Y., Ueda H., Shima K., Ogihara T. Class I HLA is associated with age-at-onset of IDDM, while class II HLA confers susceptibility to IDDM. Diabetologia. 38:1995;1493.
11. Demaine A.G., Hibberd M.L., Mangles D., Millward B.A. A new marker in the HLA class I region is associated with the age at onset of IDDM. Diabetologia. 38:1995;623.
12. Braud V.M., Allan D.S.J., O'Callaghan C.A., Soderstrom K., D'Andrea A.J., Ogg G.S., Lazetic S., Young N.T., Bell J.I., Phillips J.H., Lanier L.L., McMichael A.J. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 391:1998;795.
13. Borrego F., Ulbrecht M., Weiss E.H., Coligan J.E., Brooks A.G. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med. 187:1998;813.
14. Grimsley C., Ober C. Population genetic studies of HLA-E. Evidence for selection. Hum Immunol. 52:1997;33.
15. Arnaiz-Villena A, Chandanayingyang D, Chiewsilp P, Diaz-Campos N, Fan L, Fauchet R, Fumaki N, Guo SS, Gyodi E, Hammond M, Jersild C, Juji T, Lepage V, Martinetti M, Martinez-Laso J, Mehra N, Penzes M, Rajalingam R, Raiczy K, Tokunaga K: HLA-E polymorphism: 12th International Histocompatibility Workshop study. In Charron D (ed): HLA Genetic Diversity of HLA Functional and Medical Implication: New Genetics. 1997; 151.
16. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 28:1979;1039.
17. Tiwari J.L., Terasaki P.I. The data and statistical analysis. Tiwari J.L., Terasaki P.I. HLA and Disease Associations. 1985;18 Springer-Verlag, New York.
18. Janer M., Geraghty D.E. The human major histocompatibility complex 42,221 bp of genomic sequence, high-density sequence-tagged site map, evolution, and polymorphism for HLA class I. Genomics. 51:1998;35.
19. Foulis A.K., McGill M., Farquharson M.A. Insulitis in type 1 (insulin-dependent) diabetes mellitus in man - macrophages, lymphocytes and interferon-gamma containing cells. J Pathol. 165:1991;97.
20. Wei X., Orr H.T. Differential expression of HLA-E, HLA-F, and HLA-G transcripts in human tissues. Hum Immunol. 29:1990;131.